GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Caliway Biopharmaceuticals Co Ltd (TPE:6919) » Definitions » Policy Acquisition Expense

Caliway Biopharmaceuticals Co (TPE:6919) Policy Acquisition Expense


View and export this data going back to 2022. Start your Free Trial

What is Caliway Biopharmaceuticals Co Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Caliway Biopharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No.99, Sec. 1, Xintai 5th Road, 32rd Floor-9, Xizhi District, New Taipei City, TWN, 221
Caliway Biopharmaceuticals Co Ltd specializes in the development of new drugs for aesthetic medicine and chronic inflammation. Its pipeline candidates are CBL-514, CBA-539, and CBO-012.